SARS-CoV-2 seroprevalence and determinants of infection in young adults: a population-based seroepidemiological study
- PMID: 35490440
- PMCID: PMC8940565
- DOI: 10.1016/j.puhe.2022.03.009
SARS-CoV-2 seroprevalence and determinants of infection in young adults: a population-based seroepidemiological study
Abstract
Objectives: Most SARS-CoV-2 seroprevalence studies have focussed on adults and high-risk populations, and little is known about young adults. The objective of the present study was to provide evidence on the SARS-CoV-2 seroprevalence among young adults in Germany and to explore determinants associated with seropositivity in general and, specifically, with previously undetected infections.
Study design: This was a population-based SARS-CoV-2 seroprevalence study.
Methods: In November 2020, a population-based study on SARS-CoV-2 seroprevalence in young adults (aged 18-30 years) was conducted in a large German city. Serum samples were obtained to analyse the SARS-CoV-2 antibody status using the Elecsys Anti-SARS-CoV-2 immunoassay. Descriptive statistics and odds ratios (ORs) of seropositivity and of previously undetected infections in relation to different determinants were calculated.
Results: Among 2186 participants, SARS-CoV-2 antibodies were detected in 72 individuals, equalling a test performance-adjusted seroprevalence of 3.1% (95% confidence interval [CI]: 2.4-4.0). Based on reported COVID-19 cases to the public health authority, a moderate underascertainment rate of 1.7 was calculated. Seropositivity was higher among individuals who sought COVID-19-related information from social media (OR: 1.83, 95% CI: 1.2-3.1), and undetected COVID-19 infections were more prevalent among men and those not adhering to social distancing.
Conclusions: The results show a substantial underascertainment of SARS-CoV-2 infections among young adults and indicate that seroprevalence is likely to be much higher than the reported COVID-19 prevalence based on confirmed COVID-19 cases in Germany. Preventive efforts should consider the heterogeneity of risk profiles among the young adult population.
Keywords: COVID-19; SARS-CoV-2 antibodies; Seroprevalence; Young adults.
Copyright © 2022 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Underascertainment of COVID-19 cases among first responders: a seroepidemiological study.Occup Med (Lond). 2022 Apr 19;72(3):225-228. doi: 10.1093/occmed/kqab164. Occup Med (Lond). 2022. PMID: 34882771 Free PMC article.
-
Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.J Glob Health. 2023 Apr 21;13:06011. doi: 10.7189/jogh.13.06011. J Glob Health. 2023. PMID: 37079274 Free PMC article.
-
High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.mSphere. 2021 Dec 22;6(6):e0068521. doi: 10.1128/mSphere.00685-21. Epub 2021 Nov 24. mSphere. 2021. PMID: 34817236 Free PMC article.
-
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.PLoS Med. 2022 Nov 10;19(11):e1004107. doi: 10.1371/journal.pmed.1004107. eCollection 2022 Nov. PLoS Med. 2022. PMID: 36355774 Free PMC article.
-
Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Jun 14;19(12):7257. doi: 10.3390/ijerph19127257. Int J Environ Res Public Health. 2022. PMID: 35742506 Free PMC article.
Cited by
-
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022.Pathogens. 2023 Apr 2;12(4):551. doi: 10.3390/pathogens12040551. Pathogens. 2023. PMID: 37111436 Free PMC article.
-
Community case study for surveillance and early case-detection of SARS-CoV-2 infections across high-risk key populations: the Sentinella programme.Front Public Health. 2024 Oct 23;12:1432157. doi: 10.3389/fpubh.2024.1432157. eCollection 2024. Front Public Health. 2024. PMID: 39512710 Free PMC article.
-
Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020.Sci Rep. 2022 Nov 14;12(1):19492. doi: 10.1038/s41598-022-23821-6. Sci Rep. 2022. PMID: 36376417 Free PMC article.
-
Vaccination strategies when vaccines are scarce: on conflicts between reducing the burden and avoiding the evolution of escape mutants.J R Soc Interface. 2022 Jun;19(191):20220045. doi: 10.1098/rsif.2022.0045. Epub 2022 Jun 29. J R Soc Interface. 2022. PMID: 35765804 Free PMC article.
References
-
- Aleta A., Moreno Y. Age differential analysis of COVID-19 second wave in Europe reveals highest incidence among young adults. medRxiv. 2020:2020. 11.11.20230177.
-
- Koch-Institut Robert. 2020. Täglicher Lagebericht des RKI zur Coranavirus-Krankheit-2019 (COVID-19) 8.12.2020.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous